Zobrazeno 1 - 10
of 489
pro vyhledávání: ''
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Objective To investigate whether surgery improves prognosis in elderly patients with Merkel cell carcinoma (MCC). Materials/Methods Data of all patients with MCC diagnosed between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7060-7070 (2021)
Cancer Medicine
Cancer Medicine
Background Although primary splenic lymphoma (PSL) is rare, it ranks first among splenic primary malignant cancers, and the incidence of lymphoma of spleen has gradually increased in recent years. However, the efficacy of surgery for PSL has not been
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Purpose To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival. Methods Surveillance, Epid
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3474-3485 (2021)
Cancer Medicine
Cancer Medicine
Background The clinical characteristics and prognosis of primary intestinal diffuse large B‐cell lymphoma (PI‐DLBCL) are rarely reported. We aimed to explore the role of surgery in patients with PI‐DLBCL. Methods Adult PI‐DLBCL patients were
Autor:
Takafumi Soeno, Nobuyuki Nishizawa, Hiroki Harada, Keishi Yamashita, Hideki Ushiku, Keigo Yokoi, Naoki Hiki, Kei Hosoda
Publikováno v:
Journal of Surgical Research. 256:404-412
Background CDO1 is a presumed tumor suppressor gene in human cancers, the expression of which is silenced by promoter DNA methylation. Moreover, CDO1 harbors functionally oncogenic aspects through modification of mitochondrial membrane potential. We
Autor:
Céline Forster, Thorsten Krueger, Etienne Abdelnour-Berchtold, Matthieu Zellweger, Michel Gonzalez, Amaya Ojanguren, Sara Federici, Jean Yannis Perentes
Publikováno v:
Clinical & experimental metastasis, vol. 37, no. 6, pp. 675-682
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis
Recurrence after pulmonary metastasectomy (PM) is frequent, but it is unclear to whom repeated pulmonary metastasectomy (RPM) offers highest benefits. Retrospective analysis of oncological and post-operative outcomes of consecutive patients who under
Autor:
Hans Christian Reinhardt, Maike Wittersheim, Roland Goldbrunner, Stephanie T Jünger, Stefan Grau, Petra Schödel, Nils-Ole Schmidt, Martin Proescholdt
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7503-7510 (2020)
Cancer Medicine
Cancer Medicine
Background Brain metastases (BM) frequently cause focal neurological deficits leading to a reduced Karnofsky performance score (KPS). Since KPS is routinely used to guide the choice of adjuvant therapy, we hypothesized that improving KPS by surgical
Autor:
Testuji Naka, Zhe Jin, Shogo Kobayashi, Kunihito Gotoh, Hidetoshi Eguchi, Masaki Mori, Yuichiro Doki, Tsuyoshi Takahashi
Publikováno v:
Journal of Surgical Research. 252:147-155
Background Leucine-rich α-2-glycoprotein-1 (LRG) has been found to participate in the development of various cancers through its involvement in TGF-β1-induced epithelial-mesenchymal transition (EMT) and/or angiogenesis and can be induced by inflamm
Publikováno v:
International Journal of Clinical Oncology. 25:1334-1345
Epithelium-specific ETS 3 (ESE3) is down-regulated frequently in several malignancies and involved in carcinogenesis and progression. However, ESE3 expression pattern and its relationship with clinical features and prognosis in hepatocellular carcino
Autor:
Hiroyuki Kuge, Yasuko Matsuo, Takahiro Yoshikawa, Fumikazu Koyama, Daisuke Hokuto, Takeo Nomi, Naoki Kamitani, Shinsaku Obara, Takayuki Nakamoto, Masayuki Sho
Publikováno v:
Anticancer Research. 40:1107-1116
Background/aim The aim of this study was to evaluate whether modern chemotherapy has changed characteristics of actual five-year survivors after liver resection for colorectal liver metastasis (CRLM). Patients and methods The records of 210 patients,